Literature DB >> 25996456

Risk Communication, Values Clarification, and Vaccination Decisions.

Holly O Witteman1,2,3, Selma Chipenda Dansokho2, Nicole Exe4, Audrey Dupuis5, Thierry Provencher6, Brian J Zikmund-Fisher4,7,8,9.   

Abstract

Many health-related decisions require choosing between two options, each with risks and benefits. When presented with such tradeoffs, people often make choices that fail to align with scientific evidence or with their own values. This study tested whether risk communication and values clarification methods could help parents and guardians make evidence-based, values-congruent decisions about children's influenza vaccinations. In 2013-2014 we conducted an online 2×2 factorial experiment in which a diverse sample of U.S. parents and guardians (n = 407) were randomly assigned to view either standard information about influenza vaccines or risk communication using absolute and incremental risk formats. Participants were then either presented or not presented with an interactive values clarification interface with constrained sliders and dynamic visual feedback. Participants randomized to the risk communication condition combined with the values clarification interface were more likely to indicate intentions to vaccinate (β = 2.10, t(399) = 2.63, p < 0.01). The effect was particularly notable among participants who had previously demonstrated less interest in having their children vaccinated against influenza (β = -2.14, t(399) = -2.06, p < 0.05). When assessing vaccination status reported by participants who agreed to participate in a follow-up study six months later (n = 116), vaccination intentions significantly predicted vaccination status (OR = 1.66, 95%CI (1.13, 2.44), p < 0.05) and rates of informed choice (OR = 1.51, 95%CI (1.07, 2.13), p < 0.012), although there were no direct effects of experimental factors on vaccination rates. Qualitative analysis suggested that logistical barriers impeded immunization rates. Risk communication and values clarification methods may contribute to increased vaccination intentions, which may, in turn, predict vaccination status if logistical barriers are also addressed.
© 2015 Society for Risk Analysis.

Entities:  

Keywords:  Children; immunization; influenza; interface design; risk communication methods; vaccination; values clarification exercise; values clarification methods; values congruence

Mesh:

Year:  2015        PMID: 25996456     DOI: 10.1111/risa.12418

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  13 in total

1.  [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment].

Authors:  Sara Boccalini; Angela Bechini; Maddalena Innocenti; Gino Sartor; Federico Manzi; Paolo Bonanni; Donatella Panatto; Piero Luigi Lai; Francesca Zangrillo; Emanuela Rizzitelli; Mariasilvia Iovine; Daniela Amicizia; Chiara Bini; Andrea Marcellusi; Francesco Saverio Mennini; Alessandro Rinaldi; Francesca Trippi; Anna Maria Ferriero; Giovanni Checcucci Lisi
Journal:  J Prev Med Hyg       Date:  2018-05-30

2.  The Role of Risk Perception in Flu Vaccine Behavior among African-American and White Adults in the United States.

Authors:  Vicki S Freimuth; Amelia Jamison; Gregory Hancock; Donald Musa; Karen Hilyard; Sandra Crouse Quinn
Journal:  Risk Anal       Date:  2017-03-17       Impact factor: 4.000

Review 3.  Parents' and informal caregivers' views and experiences of communication about routine childhood vaccination: a synthesis of qualitative evidence.

Authors:  Heather Mr Ames; Claire Glenton; Simon Lewin
Journal:  Cochrane Database Syst Rev       Date:  2017-02-07

4.  Neuroeconomics, health psychology, and the interdisciplinary study of preventative health behavior.

Authors:  Krista L DeStasio; John A Clithero; Elliot T Berkman
Journal:  Soc Personal Psychol Compass       Date:  2019-10-23

Review 5.  Face-to-face interventions for informing or educating parents about early childhood vaccination.

Authors:  Jessica Kaufman; Rebecca Ryan; Louisa Walsh; Dell Horey; Julie Leask; Priscilla Robinson; Sophie Hill
Journal:  Cochrane Database Syst Rev       Date:  2018-05-08

6.  Negotiating Tensions Between Theory and Design in the Development of Mailings for People Recovering From Acute Coronary Syndrome.

Authors:  Holly O Witteman; Justin Presseau; Emily Nicholas Angl; Iffat Jokhio; J D Schwalm; Jeremy M Grimshaw; Beth Bosiak; Madhu K Natarajan; Noah M Ivers
Journal:  JMIR Hum Factors       Date:  2017-03-01

7.  Communicating infectious disease prevalence through graphics: Results from an international survey.

Authors:  Angela Fagerlin; Thomas S Valley; Aaron M Scherer; Megan Knaus; Enny Das; Brian J Zikmund-Fisher
Journal:  Vaccine       Date:  2017-06-12       Impact factor: 3.641

8.  Development and usability testing of Understanding Stroke, a tailored life-sustaining treatment decision support tool for stroke surrogate decision makers.

Authors:  Emily P Chen; Cynthia Arslanian-Engoren; William Newhouse; Diane Egleston; Savina Sahgal; Aneesha Yande; Angela Fagerlin; Darin B Zahuranec
Journal:  BMC Palliat Care       Date:  2020-07-20       Impact factor: 3.234

9.  "I don't know exactly what you're referring to": the challenge of values elicitation in decision making for implantable cardioverter-defibrillators.

Authors:  Sandra L Carroll; Gayathri Embuldeniya; Jasprit Pannag; Krystina B Lewis; Jeff S Healey; Michael McGillion; Lehana Thabane; Dawn Stacey
Journal:  Patient Prefer Adherence       Date:  2018-09-28       Impact factor: 2.711

10.  Understanding Vaccine Hesitancy in Canada: Results of a Consultation Study by the Canadian Immunization Research Network.

Authors:  Eve Dubé; Dominique Gagnon; Manale Ouakki; Julie A Bettinger; Maryse Guay; Scott Halperin; Kumanan Wilson; Janice Graham; Holly O Witteman; Shannon MacDonald; William Fisher; Laurence Monnais; Dat Tran; Arnaud Gagneur; Juliet Guichon; Vineet Saini; Jane M Heffernan; Samantha Meyer; S Michelle Driedger; Joshua Greenberg; Heather MacDougall
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.